181 related articles for article (PubMed ID: 19342453)
1. Characterization of intracellular signaling mediated by human somatostatin receptor 5: role of the DRY motif and the third intracellular loop.
Peverelli E; Lania AG; Mantovani G; Beck-Peccoz P; Spada A
Endocrinology; 2009 Jul; 150(7):3169-76. PubMed ID: 19342453
[TBL] [Abstract][Full Text] [Related]
2. The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation.
Peverelli E; Mantovani G; Calebiro D; Doni A; Bondioni S; Lania A; Beck-Peccoz P; Spada A
Mol Endocrinol; 2008 Mar; 22(3):676-88. PubMed ID: 18096696
[TBL] [Abstract][Full Text] [Related]
3. Homologous and heterologous in vitro regulation of pig pituitary somatostatin receptor subtypes, sst1, sst2 and sst5 mRNA.
Luque RM; Park S; Peng XD; Delgado E; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP
J Mol Endocrinol; 2004 Apr; 32(2):437-48. PubMed ID: 15072550
[TBL] [Abstract][Full Text] [Related]
4. Specific roles of G(i) protein family members revealed by dissecting SST5 coupling in human pituitary cells.
Peverelli E; Busnelli M; Vitali E; Giardino E; Galés C; Lania AG; Beck-Peccoz P; Chini B; Mantovani G; Spada A
J Cell Sci; 2013 Jan; 126(Pt 2):638-44. PubMed ID: 23178946
[TBL] [Abstract][Full Text] [Related]
5. Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonist.
Rajeswaran WG; Hocart SJ; Murphy WA; Taylor JE; Coy DH
J Med Chem; 2001 Apr; 44(8):1305-11. PubMed ID: 11312929
[TBL] [Abstract][Full Text] [Related]
6. Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways.
Cescato R; Loesch KA; Waser B; Mäcke HR; Rivier JE; Reubi JC; Schonbrunn A
Mol Endocrinol; 2010 Jan; 24(1):240-9. PubMed ID: 19910453
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of somatostatin and angiopeptin on cell proliferation.
Alderton F; Lauder H; Feniuk W; Fan TP; Humphrey PP
Br J Pharmacol; 1998 May; 124(2):323-30. PubMed ID: 9641549
[TBL] [Abstract][Full Text] [Related]
8. Identification of the somatostatin receptor subtypes (sst) mediating the divergent, stimulatory/inhibitory actions of somatostatin on growth hormone secretion.
Luque RM; Durán-Prado M; García-Navarro S; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP
Endocrinology; 2006 Jun; 147(6):2902-8. PubMed ID: 16543371
[TBL] [Abstract][Full Text] [Related]
9. Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization.
Durán-Prado M; Bucharles C; Gonzalez BJ; Vázquez-Martínez R; Martínez-Fuentes AJ; García-Navarro S; Rhodes SJ; Vaudry H; Malagón MM; Castaño JP
Endocrinology; 2007 Jan; 148(1):411-21. PubMed ID: 17053026
[TBL] [Abstract][Full Text] [Related]
10. Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line.
Cambiaghi V; Vitali E; Morone D; Peverelli E; Spada A; Mantovani G; Lania AG
Endocrine; 2017 Apr; 56(1):146-157. PubMed ID: 27406390
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5.
Cordelier P; Estève JP; Bousquet C; Delesque N; O'Carroll AM; Schally AV; Vaysse N; Susini C; Buscail L
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9343-8. PubMed ID: 9256484
[TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro.
Zatelli MC; Piccin D; Tagliati F; Bottoni A; Ambrosio MR; Margutti A; Scanarini M; Bondanelli M; Culler MD; degli Uberti EC
J Mol Endocrinol; 2005 Oct; 35(2):333-41. PubMed ID: 16216913
[TBL] [Abstract][Full Text] [Related]
13. Selective regulation of somatostatin receptor subtype signaling: evidence for constitutive receptor activation.
Ben-Shlomo A; Pichurin O; Barshop NJ; Wawrowsky KA; Taylor J; Culler MD; Chesnokova V; Liu NA; Melmed S
Mol Endocrinol; 2007 Oct; 21(10):2565-78. PubMed ID: 17609435
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents.
Córdoba-Chacón J; Gahete MD; Duran-Prado M; Pozo-Salas AI; Malagón MM; Gracia-Navarro F; Kineman RD; Luque RM; Castaño JP
Cell Mol Life Sci; 2010 Apr; 67(7):1147-63. PubMed ID: 20063038
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors.
Durán-Prado M; Gahete MD; Martínez-Fuentes AJ; Luque RM; Quintero A; Webb SM; Benito-López P; Leal A; Schulz S; Gracia-Navarro F; Malagón MM; Castaño JP
J Clin Endocrinol Metab; 2009 Jul; 94(7):2634-43. PubMed ID: 19401364
[TBL] [Abstract][Full Text] [Related]
16. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins.
Carruthers AM; Warner AJ; Michel AD; Feniuk W; Humphrey PP
Br J Pharmacol; 1999 Mar; 126(5):1221-9. PubMed ID: 10205012
[TBL] [Abstract][Full Text] [Related]
17. Regulation of neuronal nitric-oxide synthase activity by somatostatin analogs following SST5 somatostatin receptor activation.
Cordelier P; Estève JP; Najib S; Moroder L; Vaysse N; Pradayrol L; Susini C; Buscail L
J Biol Chem; 2006 Jul; 281(28):19156-71. PubMed ID: 16690617
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
[TBL] [Abstract][Full Text] [Related]
19. Differential involvement of signaling pathways in the regulation of growth hormone release by somatostatin and growth hormone-releasing hormone in orange-spotted grouper (Epinephelus coioides).
Wang B; Qin C; Zhang C; Jia J; Sun C; Li W
Mol Cell Endocrinol; 2014 Feb; 382(2):851-9. PubMed ID: 24183819
[TBL] [Abstract][Full Text] [Related]
20. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD
Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
